Drug
Follitropin Alfa Beta
Follitropin Alfa Beta: highest development phase Approved, developed by Merck KGaA. 1 trial record tracked on RxWires.
- Highest phase
- Approved
- Developer
- Merck KGaA
Trials
| Drug | Phase | Indication |
|---|---|---|
| GONAL-F RFF REDI-JECT | Approved |
Latest
No recent events.
Follow Follitropin Alfa Beta on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.